Managers / Q4 2021 · view latest →
VILLERE ST DENIS J & CO LLC
CIK 0001113629 · 601 POYDRAS ST., SUITE 1808, NEW ORLEANS, LA, 70130 · 504-525-0808
Summary
Villere St Denis J & Co LLC reported $1.7B in U.S.-listed holdings across 61 positions for Q4 2021.
Its largest position, ON, represents 6.2% of the portfolio.
Compared with Q3 2021, the fund opened 2 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.7% · $1.6B
- Other · 5.2% · $91M
- PUBLIC · 1.1% · $19M
- Closed-End Fund · 0.0% · $324,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BK OF AMERICA CORP | NEW | +13.3K | 13.3K | +$19M | $19M |
| BMYBRISTOL-MYERS SQUIBB CO | NEW | +3.3K | 3.3K | +$205,000 | $205,000 |
| EHTHEHEALTH INC | SOLD OUT | −1.12M | 0 | −$45M | $0 |
| OMCLOMNICELL COM | SOLD OUT | −46.9K | 0 | −$7M | $0 |
| TAT&T INC | SOLD OUT | −7.5K | 0 | −$201,000 | $0 |
| PROSHARES TR | SOLD OUT | −12.5K | 0 | −$107,000 | $0 |
| PROSHARES TR | SOLD OUT | −10.4K | 0 | −$100,000 | $0 |
| MCHPMICROCHIP TECHNOLOGY INC. | ADDED | +135.3K | 271.8K | +$3M | $24M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $907M | 76 | Apr 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $997M | 80 | Jan 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.0B | 81 | Nov 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.0B | 81 | Jul 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.0B | 83 | Apr 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.1B | 85 | Jan 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.2B | 86 | Nov 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.2B | 86 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.3B | 83 | Apr 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.2B | 76 | Jan 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.2B | 67 | Oct 20, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.4B | 65 | Jul 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 59 | Apr 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 65 | Jan 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.3B | 61 | Oct 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.3B | 60 | Jul 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.7B | 60 | Apr 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.7B | 61 | Jan 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.7B | 64 | Oct 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.9B | 60 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.8B | 58 | Apr 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.7B | 57 | Jan 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.5B | 57 | Oct 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.4B | 53 | Jul 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.2B | 46 | Apr 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.5B | 48 | Jan 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.5B | 42 | Oct 22, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.6B | 45 | Jul 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.5B | 46 | May 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.4B | 51 | Jan 22, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.